AbbVie Inc (ABBV)

Financial leverage ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Total assets US$ in thousands 134,711,000 136,221,000 135,367,000 134,544,000 138,805,000 141,325,000 143,186,000 143,211,000 146,529,000 148,858,000 147,972,000 150,501,000 150,565,000 149,621,000 149,530,000 91,199,000 89,115,000 59,441,000 57,142,000 56,769,000
Total stockholders’ equity US$ in thousands 10,360,000 12,094,000 12,866,000 13,274,000 17,254,000 15,994,000 14,653,000 16,283,000 15,408,000 13,550,000 12,569,000 13,710,000 13,076,000 15,270,000 14,708,000 -7,415,000 -8,172,000 -8,226,000 -8,566,000 -7,826,000
Financial leverage ratio 13.00 11.26 10.52 10.14 8.04 8.84 9.77 8.80 9.51 10.99 11.77 10.98 11.51 9.80 10.17

December 31, 2023 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $134,711,000K ÷ $10,360,000K
= 13.00

The financial leverage ratio of Abbvie Inc has exhibited an increasing trend over the recent quarters, indicating a rising level of leverage in the company's capital structure. The ratio stood at 13.00 in Q4 2023, showing a significant increase from the previous quarter's ratio of 11.26 in Q3 2023. This suggests that Abbvie Inc has been relying more on debt financing compared to equity in the most recent quarter.

Looking at the trend over the past year, the financial leverage ratio has generally been on an upward trajectory, starting at 8.80 in Q1 2022 and gradually increasing to 13.00 in Q4 2023. This signifies a persistent buildup of leverage in the company's operations and could potentially imply higher financial risk.

A higher financial leverage ratio indicates a higher proportion of debt in the company's capital structure, which can magnify returns on equity but also increase the risk of financial distress, especially during economic downturns or unfavorable business conditions. It is essential for investors and stakeholders to closely monitor Abbvie Inc's leverage levels and assess the company's ability to manage its debt obligations effectively.


Peer comparison

Dec 31, 2023


See also:

AbbVie Inc Financial Leverage (Quarterly Data)